<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Typhoid fever</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Typhoid fever.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/typhoid-fever.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Efektivitas Penggunaan Obat Antibiotik pada Pasien Demam &lt;i&gt;Typhoid&lt;/i&gt;</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-67865-wp6f3871-cd79ddf8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-67865-wp6f3871-cd79ddf8/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Assessing these treatment metrics addresses documented concerns regarding therapeutic failure, mortality risks, and potential antimicrobial resistance development.</description>
    <category>Typhoid fever</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Prioritizing the introduction of new vaccine in Tanzania (2026–2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128985-3837733d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128985-3837733d/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The documented scoring mechanism enables resource-limited jurisdictions to conduct systematic, transparent evaluations when expanding routine immunization programs.</description>
    <category>Hepatitis B</category>
    <category>Malaria</category>
    <category>Typhoid fever</category>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00358-0-b88ea3a1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00358-0-b88ea3a1/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support the WHO recommendation of oral azithromycin monotherapy for uncomplicated typhoid fever and provide no evidence to justify adding cefixime, which has important antimicrobial stewardship implications given concerns about dual-drug resistance emergence.</description>
    <category>Typhoid fever</category>
    <category>COVID-19</category>
    <category>Dengue</category>
    <category>Malaria</category>
    <category>Typhus</category>
    <category>Scrub Typhus</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) vaccine introduction in Nepal: A test-negative, case-control study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The documented high protection rate suggests utility for national immunization programs aiming to reduce severe bacterial enteric disease in endemic regions.</description>
    <category>Typhoid fever</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Genomic epidemiology and antimicrobial resistance reveal local transmission dynamics of enteric fever in Shenzhen, one of the mega cities in China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106469-c4631148/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106469-c4631148/</guid>
    <pubDate>Tue, 01 Apr 2025 00:00:00 GMT</pubDate>
    <description>Mapping these genetic and resistance patterns assists authorities in anticipating spread routes and prioritizing monitoring efforts in densely populated regions.</description>
    <category>Typhoid fever</category>
    <category>Paratyphoid fever</category>
    <category>Outbreak investigation</category>
    <category>Antimicrobial resistance</category>
    <category>Genomic epidemiology</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Case-control investigation of invasive Salmonella disease in Malawi reveals no evidence of environmental or animal transmission of invasive strains, and supports human to human transmission</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010982-aa90c595/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010982-aa90c595/</guid>
    <pubDate>Mon, 12 Dec 2022 00:00:00 GMT</pubDate>
    <description>The study is relevant to understanding invasive Salmonella transmission in a household and One Health context in Malawi. It also highlights the value of household sampling for transmission-oriented epidemiology and the challenge of detecting S. Typhi from the environment.</description>
    <category>Typhoid fever</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Spatial and Genomic Data to Characterize Endemic Typhoid Transmission</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab745-fafd315d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab745-fafd315d/</guid>
    <pubDate>Tue, 31 Aug 2021 00:00:00 GMT</pubDate>
    <description>The authors indicate that combining genomic and spatial information may help identify areas with higher incidence and inform targeted environmental surveillance and typhoid control strategies. These implications are presented as applications of the study findings, not as evidence that such interventions were evaluated.</description>
    <category>Typhoid fever</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007955-be2809f8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007955-be2809f8/</guid>
    <pubDate>Thu, 26 Dec 2019 00:00:00 GMT</pubDate>
    <description>The findings are relevant to first-line therapy of uncomplicated enteric fever in the context of emerging antimicrobial resistance, and motivate further work on azithromycin dosing regimens and combination strategies.</description>
    <category>Typhoid fever</category>
    <category>Paratyphoid fever</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004616-5e37ce6d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004616-5e37ce6d/</guid>
    <pubDate>Fri, 15 Apr 2016 00:00:00 GMT</pubDate>
    <description>The findings indicate that typhoid remains a significant public health challenge in India despite apparent declines in prevalence, particularly among young children, and suggest that newly-licensed conjugate vaccines for infant immunization could address this burden, especially amid growing antimicrobial resistance.</description>
    <category>Paratyphoid fever</category>
    <category>Typhoid fever</category>
    <category>Typhoid and Paratyphoid fever</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Systematic review</category>
  </item>
</channel>
</rss>
